Frequently Asked Questions about InflaRx N.V. (IFRX)

Name: InflaRx N.V. (IFRX) Institutional Financial Dataset
Creator: Olyth
License: https://olyth.xyz

Question 1

What does InflaRx N.V. (IFRX) do?

Accepted Answer

InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. I...

Question 2

Is InflaRx N.V. (IFRX) a good stock to buy?

Accepted Answer

Olyth's institutional analysis of IFRX reveals an Altman Z-Score of -8.82 and a Piotroski F-Score of 1/9. These metrics, combined with its 5-year revenue trend ($0.00B most recent), help investors decide if IFRX fits their risk profile.

Question 3

What is the current P/E ratio for IFRX?

Accepted Answer

As of the latest trading session, InflaRx N.V. (IFRX) has a trailing P/E ratio of -1.31.

Question 4

Who is the CEO of InflaRx N.V.?

Accepted Answer

The current Chief Executive Officer of InflaRx N.V. is Niels C. Riedemann.

Question 5

What was IFRX's revenue for the last 5 years?

Accepted Answer

According to its latest income statements, InflaRx N.V. reported annual revenues of $0.00B (2025), $0.00B (2024), $0.00B (2023), $0.00B (2022), $0.00B (2021) respectively.

Question 6

Does IFRX pay a dividend?

Accepted Answer

InflaRx N.V. does not currently pay a dividend to its shareholders.

Question 7

How much debt and cash flow does IFRX have?

Accepted Answer

In its latest reporting period, InflaRx N.V. generated $-0.03B in Free Cash Flow against a total debt load of $0.00B.

Question 8

What is the Price-to-Book (P/B) ratio of InflaRx N.V.?

Accepted Answer

The Price-to-Book (P/B) ratio for InflaRx N.V. (IFRX) is currently 1.38.

Question 9

What is the Price-to-Sales (P/S) ratio of IFRX?

Accepted Answer

Based on trailing twelve-month data, InflaRx N.V. (IFRX) trades at a Price-to-Sales (P/S) ratio of 2187.80.

Question 10

What is InflaRx N.V.'s Return on Equity (ROE)?

Accepted Answer

InflaRx N.V. (IFRX) has a Return on Equity (ROE) of -81.77%, representing its profitability relative to shareholder equity.